Aspiration-assisted bioprinting for precise positioning of biologics.

Published on Mar 6, 2020in Science Advances11.5
· DOI :10.1126/SCIADV.AAW5111
Bugra Ayan5
Estimated H-index: 5
(PSU: Pennsylvania State University),
Dong Nyoung Heo18
Estimated H-index: 18
(Kyung Hee University)
+ 4 AuthorsIbrahim T. Ozbolat25
Estimated H-index: 25
Three-dimensional (3D) bioprinting is an appealing approach for building tissues; however, bioprinting of mini-tissue blocks (i.e., spheroids) with precise control on their positioning in 3D space has been a major obstacle. Here, we unveil “aspiration-assisted bioprinting (AAB),” which enables picking and bioprinting biologics in 3D through harnessing the power of aspiration forces, and when coupled with microvalve bioprinting, it facilitated different biofabrication schemes including scaffold-based or scaffold-free bioprinting at an unprecedented placement precision, ~11% with respect to the spheroid size. We studied the underlying physical mechanism of AAB to understand interactions between aspirated viscoelastic spheroids and physical governing forces during aspiration and bioprinting. We bioprinted a wide range of biologics with dimensions in an order-of-magnitude range including tissue spheroids (80 to 600 μm), tissue strands (~800 μm), or single cells (electrocytes, ~400 μm), and as applications, we illustrated the patterning of angiogenic sprouting spheroids and self-assembly of osteogenic spheroids.
  • References (55)
  • Citations (0)
📖 Papers frequently viewed together
45 Citations
81 Citations
4 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Mee-Hae Kim (Osaka University)H-Index: 10
#2Kazuhiro Takeuchi (Osaka University)H-Index: 1
Last. Masahiro Kino-oka (Osaka University)H-Index: 22
view all 3 authors...
Clinical and industrial applications require large quantities of human induced pluripotent stem cells (hiPSCs); however, little is known regarding the mechanisms governing aggregate formation and stability in suspension culture. To address this, we determined differences in growth processes among hiPSC lines in suspension culture. Using an hiPSC aggregate suspension culture system, hiPSCs from different lines formed multicellular aggregates classified as large compact or small loose based on the...
2 CitationsSource
#1Yang Wu (PSU: Pennsylvania State University)H-Index: 4
#2Monika Hospodiuk (PSU: Pennsylvania State University)H-Index: 5
Last. Ibrahim T. OzbolatH-Index: 25
view all 8 authors...
1 CitationsSource
#1Monika Hospodiuk (PSU: Pennsylvania State University)H-Index: 5
#2Madhuri Dey (PSU: Pennsylvania State University)H-Index: 6
Last. Ibrahim T. OzbolatH-Index: 25
view all 7 authors...
Despite the recent achievements in cell-based therapies for curing type-1 diabetes (T1D), capillarization in beta (β)-cell clusters is still a major roadblock as it is essential for long-term viability and function of β-cells in vivo. In this research, we report sprouting angiogenesis in engineered pseudo islets (EPIs) made of mouse insulinoma βTC3 cells and rat heart microvascular endothelial cells (RHMVECs). Upon culturing in three-dimensional (3D) constructs under angiogenic conditions, EPIs ...
5 CitationsSource
#1Naveen V. Mekhileri (University of Otago)H-Index: 2
#2Khoon S. Lim (University of Otago)H-Index: 11
Last. Tim B. F. Woodfield (University of Otago)H-Index: 28
view all 7 authors...
Bottom-up biofabrication approaches combining micro-tissue fabrication techniques with extrusion-based 3D printing of thermoplastic polymer scaffolds are emerging strategies in tissue engineering. These biofabrication strategies support native self-assembly mechanisms observed in developmental stages of tissue or organoid growth as well as promoting cell-cell interactions and cell differentiation capacity. Few technologies have been developed to automate the precise assembly of micro-tissues or ...
27 CitationsSource
#1Weijie Peng (PSU: Pennsylvania State University)H-Index: 4
#2Pallab Datta (Indian Institute of Engineering Science and Technology, Shibpur)H-Index: 12
Last. Ibrahim T. Ozbolat (PSU: Pennsylvania State University)H-Index: 25
view all 7 authors...
Three-dimensional (3D) organoids have shown advantages in cell culture over traditional two-dimensional (2D) culture, and have great potential in various applications of tissue engineering. However, there are limitations in current organoid fabrication technologies, such as uncontrolled size, poor reproductively, and inadequate complexity of organoids. In this chapter, we present the existing techniques and discuss the major challenges for 3D organoid biofabrication. Future perspectives on organ...
4 CitationsSource
#1E. A. BulanovaH-Index: 3
Last. Vladimir MironovH-Index: 34
view all 15 authors...
Bioprinting can be defined as additive biofabrication of 3D tissues and organ constructs using tissue spheroids, capable of self-assembly, as building blocks. Thyroid gland, a relatively simple endocrine organ, is suitable for testing the proposed bioprinting technology. Here we report the bioprinting of functional vascularized mouse thyroid gland construct from embryonic tissue spheroids as a proof of concept. Based on the self-assembly principle, we generated thyroid tissue starting from thyro...
23 CitationsSource
#1Weijie Peng (PSU: Pennsylvania State University)H-Index: 4
#2Pallab Datta (Indian Institute of Engineering Science and Technology, Shibpur)H-Index: 12
Last. Ibrahim T. OzbolatH-Index: 25
view all 6 authors...
Abstract Successful launch of a commercial drug requires significant investment of time and financial resources wherein late-stage failures become a reason for catastrophic failures in drug discovery. This calls for infusing constant innovations in technologies, which can give reliable prediction of efficacy, and more importantly, toxicology of the compound early in the drug discovery process before clinical trials. Though computational advances have resulted in more rationale in silico designin...
44 CitationsSource
#1Nicanor I. Moldovan (IUPUI: Indiana University – Purdue University Indianapolis)H-Index: 4
#1Nicanor I. Moldovan (IU: Indiana University)H-Index: 2
Last. Koichi Nakayama (Saga University)H-Index: 13
view all 3 authors...
Bioprinting is a technology with the prospect to change the way many diseases are treated, by replacing the damaged tissues with live de novo created biosimilar constructs. However, after more than a decade of incubation and many proofs of concept, the field is still in its infancy. The current stagnation is the consequence of its early success: the first bioprinters, and most of those that followed, were modified versions of the three-dimensional printers used in additive manufacturing, redesig...
45 CitationsSource
#1Ludwig Gutzweiler (University of Freiburg)H-Index: 6
#2Sabrina Kartmann (University of Freiburg)H-Index: 4
Last. Stefan Zimmermann (University of Freiburg)H-Index: 10
view all 9 authors...
We present (1) a fast and automated method for large scale production of HUVEC spheroids based on the hanging drop method and (2) a novel method for well-controlled lateral deposition of single spheroids by drop-on-demand printing. Large scale spheroid production is achieved via printing 1536 droplets of HUVEC cell suspension having a volume of 1 μl each within 3 min at a pitch of 2.3 mm within an array of 48 × 32 droplets onto a flat substrate. Printing efficiencies between 97.9% and 100% and p...
11 CitationsSource
#1Pallab Datta (Indian Institute of Engineering Science and Technology, Shibpur)H-Index: 12
#2Bugra Ayan (PSU: Pennsylvania State University)H-Index: 5
Last. Ibrahim T. OzbolatH-Index: 25
view all 3 authors...
Abstract Bioprinting is a promising technology to fabricate design-specific tissue constructs due to its ability to create complex, heterocellular structures with anatomical precision. Bioprinting enables the deposition of various biologics including growth factors, cells, genes, neo-tissues and extra-cellular matrix-like hydrogels. Benefits of bioprinting have started to make a mark in the fields of tissue engineering, regenerative medicine and pharmaceutics. Specifically, in the field of tissu...
81 CitationsSource
Cited By0